行情

NVCR

NVCR

Novocure
NASDAQ

实时行情|Nasdaq Last Sale

66.28
+1.76
+2.73%
盘前: 65.00 -1.28 -1.93% 08:08 04/03 EDT
开盘
63.38
昨收
64.52
最高
66.66
最低
63.01
成交量
103.67万
成交额
--
52周最高
98.84
52周最低
41.51
市值
66.04亿
市盈率(TTM)
-823.3540
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测NVCR价格均价为88.86,最高价位105.00,最低价为75.00。

EPS

NVCR 新闻

更多
  • 全球抗疫:要么一荣俱荣,要么全盘皆输
  • 新浪财经 · 34分钟前
  • “50美分”交易员狂赚4亿美元后,将目标转向黄金
  • 新浪财经综合 · 1小时前
  • 当两个明斯基过程遭遇大幅冲击:美国企业面临大考
  • 新浪财经-自媒体综合 · 1小时前
  • 瑞幸“造假门”后:中介机构或连坐 被监管纳入核查
  • 新浪财经 · 1小时前

所属板块

医疗设备、用品及经销
+2.77%
医疗设备和用品
+3.33%

热门股票

代码
价格
涨跌幅

NVCR 简况

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM) and to advance programs testing of TTFields in multiple solid tumor indications through its clinical pipeline. In addition to its clinical and commercial progress in GBM, it is planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and mesothelioma. TTFields are delivered through a portable, medical device. The complete delivery system, which is designed to allow patients to go about their daily activities while receiving continuous cancer treatment, includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories.
展开

微牛提供Novocure Ltd(NASDAQ-NVCR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的NVCR股票新闻,以帮助您做出投资决策。